281 related articles for article (PubMed ID: 18424335)
21. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?
Genre J; Errante PR; Kokron CM; Toledo-Barros M; Câmara NO; Rizzo LV
Clin Immunol; 2009 Aug; 132(2):215-21. PubMed ID: 19394278
[TBL] [Abstract][Full Text] [Related]
22. Role of regulatory T-cells in autoimmunity.
Mellanby RJ; Thomas DC; Lamb J
Clin Sci (Lond); 2009 Apr; 116(8):639-49. PubMed ID: 19275768
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular mechanisms of immune dysregulation and autoimmunity.
Azizi G; Pouyani MR; Abolhassani H; Sharifi L; Dizaji MZ; Mohammadi J; Mirshafiey A; Aghamohammadi A
Cell Immunol; 2016 Dec; 310():14-26. PubMed ID: 27614846
[TBL] [Abstract][Full Text] [Related]
24. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
[TBL] [Abstract][Full Text] [Related]
25. Current classification and status of primary immunodeficiency diseases in Taiwan.
Liang FC; Wei YC; Jiang TH; Hsiehi MY; Wen YC; Chiou YS; Wu SH; Chen LC; Huang JL; Lee WI
Acta Paediatr Taiwan; 2008; 49(1):3-8. PubMed ID: 18581721
[TBL] [Abstract][Full Text] [Related]
26. Immunodeficiencies with autoimmune consequences.
Notarangelo LD; Gambineri E; Badolato R
Adv Immunol; 2006; 89():321-70. PubMed ID: 16682278
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
Miyara M; Wing K; Sakaguchi S
J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
[TBL] [Abstract][Full Text] [Related]
28. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies.
Carneiro-Sampaio M; Coutinho A
Adv Immunol; 2007; 95():51-82. PubMed ID: 17869610
[TBL] [Abstract][Full Text] [Related]
29. CD4+ CD25+ regulatory T cells approach the clinic.
Edinger M
Cytotherapy; 2008; 10(7):655-6. PubMed ID: 18985471
[No Abstract] [Full Text] [Related]
30. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
31. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
[TBL] [Abstract][Full Text] [Related]
32. Murine CD8+ regulatory T lymphocytes: the new era.
Pomié C; Ménager-Marcq I; van Meerwijk JP
Hum Immunol; 2008 Nov; 69(11):708-14. PubMed ID: 18817827
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
34. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
35. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
[TBL] [Abstract][Full Text] [Related]
36. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
[TBL] [Abstract][Full Text] [Related]
37. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
39. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity.
Pessach IM; Notarangelo LD
J Autoimmun; 2009 Aug; 33(1):17-24. PubMed ID: 19361956
[TBL] [Abstract][Full Text] [Related]
40. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
Sgouroudis E; Piccirillo CA
Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
